New study tests Under-the-Tongue tablet to stop Kids' colds
NCT ID NCT07578012
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tests whether PMBL® sublingual tablets can reduce the number of respiratory infections (like colds) in children aged 3 to 12 who are prone to getting sick. About 224 children will take either the active tablet or a placebo for 3 months, then be followed for 4 more months. The goal is to see if the treatment safely lowers infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS (RTI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Bialystok, Poland
-
Research Site
Bydgoszcz, Poland
-
Research Site
Krakow, Poland
-
Research Site
Krąków, Poland
-
Research Site
Lublin, Poland
-
Research Site
Oświęcim, Poland
-
Research Site
Poznan, Poland
-
Research Site
Tarnów, Poland
Conditions
Explore the condition pages connected to this study.